• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET,ADMINISTRATION,INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS® PUMP MODULE ADMINISTRATION SET; SET,ADMINISTRATION,INTRAVASCULAR Back to Search Results
Model Number PRI TUBING
Device Problem Excess Flow or Over-Infusion (1311)
Patient Problem Venipuncture (2129)
Event Date 06/07/2019
Event Type  Injury  
Manufacturer Narrative
Additional info: level after the event 3.5 ekg k+ level after the event 3.5 ekg.Although requested, device has not been received.A follow up report will be submitted with failure investigation results should the device be received for evaluation.
 
Event Description
It was reported there was a potassium over infusion event; the potassium appeared to be infusing too quickly.A primary infusion of potassium (kcl) 10meq in 100 ml was initiated, however the nurse noted 60ml had already infused several minutes after the start of the infusion.The patient required ekg (no changes), a repeat potassium level (normal range) and continuous monitoring (no changes noted).No lasting harm was reported.Although requested there were no further details of the event received.Received a copy of the customer medwatch report of (b)(6) 2019 that stated:"10meq/100ml potassium chloride started at 0659.Rn stayed with patient as drip started.At 0710, bag "seemed too empty for time hanging".Channel off button pressed.After stopping the pump to stop potassium from infusing, the potassium continued to slowly infuse.Roller camp on tubing had to be closed and patient was unhooked from iv immediately".
 
Event Description
It was reported there was a potassium over infusion event; the potassium appeared to be infusing too quickly.A primary infusion of potassium (kcl) 10meq in 100 ml was initiated, however the nurse noted 60ml had already infused several minutes after the start of the infusion.The patient required ekg (no changes), a repeat potassium level (normal range) and continuous monitoring (no changes noted).No lasting harm was reported.Although requested there were no further details of the event received.Received a copy of the customer medwatch report of 6-27-2019 that stated:"10meq/100ml potassium chloride started at 0659.Rn stayed with patient as drip started.At 0710, bag "seemed too empty for time hanging".Channel off button pressed.After stopping the pump to stop potassium from infusing, the potassium continued to slowly infuse.Roller camp on tubing had to be closed and patient was unhooked from iv immediately.".
 
Manufacturer Narrative
Additional info: the suspect has been changed from a disposable set to an instrument.Please reference the new manufacturer number 2016493-2019-00905 from e-mdr: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS® PUMP MODULE ADMINISTRATION SET
Type of Device
SET,ADMINISTRATION,INTRAVASCULAR
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key8762064
MDR Text Key150120856
Report Number9616066-2019-01785
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPRI TUBING
Device Catalogue NumberPRI TUBING
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/21/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8100,8015, TD (B)(6) 2019
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient Weight77
-
-